State of the art chemotherapeutic management of pediatric brain tumors.
about
Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells.Dose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent medulloblastoma or germinoma.Pediatric CNS tumors: current treatment and future directions.Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
P2860
State of the art chemotherapeutic management of pediatric brain tumors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
State of the art chemotherapeutic management of pediatric brain tumors.
@ast
State of the art chemotherapeutic management of pediatric brain tumors.
@en
type
label
State of the art chemotherapeutic management of pediatric brain tumors.
@ast
State of the art chemotherapeutic management of pediatric brain tumors.
@en
prefLabel
State of the art chemotherapeutic management of pediatric brain tumors.
@ast
State of the art chemotherapeutic management of pediatric brain tumors.
@en
P2093
P2860
P356
P1476
State of the art chemotherapeutic management of pediatric brain tumors.
@en
P2093
Jonathan L Finlay
Melissa J Siegel
Stergios Zacharoulis
P2860
P304
P356
10.1586/14737175.6.5.765
P577
2006-05-01T00:00:00Z